The U.S Hospital Beds Market, by Product Type (Electric Beds, Semi-Electric Beds, and Manual Beds), by Usage (Acute Care Beds, Psychiatric Care Beds, Long-Term Care Beds, and Others), by Application (Intensive Care Beds and Non-Intensive Care Beds), and by End User (Home Care Settings, Hospitals, Elderly Care Facilities, Ambulatory Surgical Centers, and Others) is estimated to be valued at US$ 1,145.4 million in 2022 and expected to exhibit a CAGR of 5.8% over the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
Key market players are focusing on organic and inorganic growth strategies, which is expected to drive the market growth over the forecast period.
For instance, in March 2020, Hill-Rom Holdings, Inc. expanded its production capacity of Intensive Care Unit (ICU) and MedSurg unit smart beds, including the company’s Progressa ICU bed and Centrella Smart+ bed.
In March 2020, Medline Industries, Inc. opened its national sales support center in Illinois, U.S., to provide customized customer solutions.
U.S Hospital Beds Market – Impact of Coronavirus (COVID-19) Pandemic
Due to the COVID-19 pandemic, a public health emergency, there was an increased demand for hospital beds. In April 2020, the Institute for Health Metrics and Evaluation (IHME) estimated a shortage of 16,323 beds in the U.S.
For instance, according to the Centers for Disease Control and Prevention (CDC), the 7-day daily average of hospitalization for January 5, 2022 to 11 January 20222 was 20, 637, a 24% increase from the prior 7-day average (16,571) from December 29, 2021 to January 4, 2022.